PD1/PDL1 clinical trials adapt to a growing landscape of patients resistant to PDx

Nat Rev Drug Discov. 2023 Dec;22(12):944-945. doi: 10.1038/d41573-023-00179-6.
No abstract available

Publication types

  • News

MeSH terms

  • B7-H1 Antigen*
  • Humans
  • Programmed Cell Death 1 Receptor*

Substances

  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor